|
US5853719A
(en)
*
|
1996-04-30 |
1998-12-29 |
Duke University |
Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA
|
|
SE9604581D0
(sv)
*
|
1996-12-12 |
1996-12-12 |
Karolinska Innovations Ab |
An agent against cancer and virus infections
|
|
US6228640B1
(en)
|
1997-02-07 |
2001-05-08 |
Cem Cezayirli |
Programmable antigen presenting cell of CD34 lineage
|
|
US6977073B1
(en)
|
1997-02-07 |
2005-12-20 |
Cem Cezayirli |
Method for stimulating an immune response
|
|
US6251665B1
(en)
|
1997-02-07 |
2001-06-26 |
Cem Cezayirli |
Directed maturation of stem cells and production of programmable antigen presenting dentritic cells therefrom
|
|
JP2001515064A
(ja)
*
|
1997-08-15 |
2001-09-18 |
フランソワ・スーシー |
クラスト−ラクタシスチンβ−ラクトンおよびそのアナログの合成
|
|
US6133308A
(en)
*
|
1997-08-15 |
2000-10-17 |
Millennium Pharmaceuticals, Inc. |
Synthesis of clasto-lactacystin beta-lactone and analogs thereof
|
|
EP1518927A3
(en)
*
|
1998-02-11 |
2005-06-22 |
Maxygen, Inc. |
Optimization of immunomodulatory properties of genetic vaccines
|
|
US7390619B1
(en)
|
1998-02-11 |
2008-06-24 |
Maxygen, Inc. |
Optimization of immunomodulatory properties of genetic vaccines
|
|
EP1053343A2
(en)
*
|
1998-02-11 |
2000-11-22 |
Maxygen, Inc. |
Targeting of genetic vaccine vectors
|
|
WO1999047102A2
(en)
*
|
1998-03-20 |
1999-09-23 |
Genzyme Corporation |
Methods for enhanced antigen presentation on antigen-presenting cells and compositions produced thereby
|
|
US6436392B1
(en)
*
|
1998-05-20 |
2002-08-20 |
University Of Iowa Research Foundation |
Adeno-associated virus vectors
|
|
GB9817693D0
(en)
*
|
1998-08-14 |
1998-10-07 |
Bridgehead Technologies Limite |
Virally-mediated targeting of drugs and genetic material
|
|
CA2362426A1
(en)
*
|
1999-02-10 |
2000-08-17 |
Takashi Tsuruo |
Anticancer drug enhancer
|
|
US7122335B1
(en)
*
|
1999-06-08 |
2006-10-17 |
University Of Iowa Research Foundation |
Compounds and methods to enhance rAAV transduction
|
|
JP4969002B2
(ja)
*
|
1999-06-08 |
2012-07-04 |
ユニバーシテイ・オブ・アイオワ・リサーチ・フアウンデーシヨン |
ｒＡＡＶ形質導入を増加するための化合物および方法
|
|
AT408721B
(de)
*
|
1999-10-01 |
2002-02-25 |
Cistem Biotechnologies Gmbh |
Pharmazeutische zusammensetzung enthaltend ein antigen
|
|
US7241447B1
(en)
*
|
1999-10-07 |
2007-07-10 |
University Of Iowa Research Foundation |
Adeno-associated virus vectors and uses thereof
|
|
US6649593B1
(en)
*
|
1999-10-13 |
2003-11-18 |
Tularik Inc. |
Modulators of SREBP processing
|
|
CA2520028A1
(en)
*
|
2003-03-31 |
2004-10-21 |
University Of Iowa Research Foundation |
Compounds and methods to enhance raav transduction
|
|
US20060167106A1
(en)
*
|
2004-11-19 |
2006-07-27 |
Mei Zhang |
Compounds acting at the centrosome
|
|
WO2007120863A2
(en)
|
2006-04-14 |
2007-10-25 |
Epicentre Technologies |
Kits and methods for generating 5' capped rna
|
|
CA2651180A1
(en)
*
|
2006-04-28 |
2007-11-08 |
University Of Iowa Research Foundation |
Methods and compounds to alter virus infection
|
|
DK2051987T3
(en)
|
2006-08-18 |
2015-01-05 |
Argos Therapeutics Inc |
USE OF CD83 IN COMBINATION THERAPY
|
|
EP2557089A2
(en)
|
2011-07-15 |
2013-02-13 |
Fundació Institut d'Investigació Biomèdica de Bellvitge (IDIBELL) |
Compositions and methods for immunomodulation
|
|
US11702672B2
(en)
|
2016-02-08 |
2023-07-18 |
University Of Iowa Research Foundation |
Methods to produce chimeric adeno-associated virus/bocavirus parvovirus
|
|
US11684679B2
(en)
|
2016-03-07 |
2023-06-27 |
University Of Iowa Research Foundation |
AAV-mediated expression using a synthetic promoter and enhancer
|
|
US12173305B2
(en)
|
2016-05-26 |
2024-12-24 |
University Of Iowa Research Foundation |
cis and trans requirements for terminal resolution of human bocavirus 1
|
|
WO2018132747A1
(en)
|
2017-01-13 |
2018-07-19 |
University Of Iowa Research Foundation |
Bocaparvovirus small noncoding rna and uses thereof
|